Gveza Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Each film-coated tablet contains 3 mg drospirenone and 0.030 mg ethinylestradiol.
Excipient with known effect: Each tablet contains 62.00 mg lactose monohydrate.
Excipients/Inactive Ingredients: Tablet core: Lactose monohydrate, Maize starch, Pregelatinized starch (maize), Crospovidone (Plasdone XL-10), Crospovidone (Plasdone XL), Povidone K-30, Polysorbate 80 (Tween 80), Magnesium stearate.
Film-coating: Polyvinyl alcohol-partial hydrolyzed, Titanium dioxide (E171), Macrogol 3350, Talc, Yellow iron oxide (E172).

ethinylestradiol + drospirenone

Manufacturer:

NaariEsta

Distributor:

Zuellig Pharma